Predictive Value of Uterine Artery Pulse Index Combined with Serum β-HCG Level in Late-Onset Fetal Intrauterine Growth Restriction in the Second Trimester
LI Xina, XU Ning, WANG Fuli
Department of Ultrasonic Imaging Center, Xi'an People's Hospital(Xi'an Fourth Hospital), Xi'an Shaanxi 710000
Abstract:【Objective】To investigate the value of uterine artery pulsation index (PI) combined with serum β-subunit human chorionic gonadotropin (β-HCG) level in predicting intrauterine growth restriction in late-onset fetuses during the second trimester. 【Methods】A total of 179 pregnant women were selected from Xi'an People's Hospital(Xi'an Fourth Hospital) from January 2019 to December 2023. According to the occurrence of growth restriction, they were divided into the late-onset intrauterine growth restriction group and non-late-onset intrauterine growth restriction group. PI and β-HCG were measured during the second trimester. Logistic regression was used to analyze the risk factors of intrauterine growth restriction in late-onset fetuses. We also analyzed the value of uterine artery ultrasound PI combined with β-HCG in predicting late-onset fetal intrauterine growth restriction in the second trimester. 【Results】There were 31 cases of late-onset intrauterine growth restriction (17.32%) in pregnant women, which were classified as late-onset intrauterine growth restriction group and 148 cases of non-late-onset intrauterine growth restriction group. There was no statistical significance in age, gestational time, family history of hypertension during pregnancy, systolic blood pressure, TC and albumin between late and non-late intrauterine growth restriction group (P>0.05). The levels of PI, β-HCG and gestational age in the late intrauterine growth restriction group were higher than those in the non-late intrauterine growth restriction group (P<0.05). The occurrence of late-onset fetal intrauterine growth restriction was taken as the dependent variable, and PI and β-HCG were taken as independent variables for Logistic multivariate regression analysis (assignment: PI and β-HCG levels were continuous variables), the results showed that PI and β-HCG were risk factors for late-onset intrauterine growth restriction (P<0.05). ROC curve results showed that the AUC value of PI combined with β-HCG in predicting late-onset intrauterine growth restriction was 0.937, which was higher than that predicted alone (P<0.05). 【Conclusion】Both PI and β-HCG are closely related to intrauterine growth restriction of late-onset fetuses, and they can be used to predict intrauterine growth restriction of late-onset fetuses, while the prediction efficiency of PI and β-HCG combined value is higher than either PI or β-HCG alone.
李西娜, 徐宁, 王富丽. 孕中期子宫动脉搏动指数联合血清β-HCG水平对孕妇发生晚发型胎儿宫内生长受限的预测价值[J]. 医学临床研究, 2024, 41(8): 1121-1123.
LI Xina, XU Ning, WANG Fuli. Predictive Value of Uterine Artery Pulse Index Combined with Serum β-HCG Level in Late-Onset Fetal Intrauterine Growth Restriction in the Second Trimester. JOURNAL OF CLINICAL RESEARCH, 2024, 41(8): 1121-1123.
[1] 黎巧儿,李玉华,张红环. 多普勒超声监测心肌做功指数对胎儿宫内生长受限的预测价值[J].深圳中西医结合杂志,2020,30(1):88-90.
[2] KRIECHBAUM S D, RUDOLPH F, WIEDENROTH C B, et al.Pregnancy-associated plasma protein A - a new indicator of pulmonary vascular remodeling in chronic thromboembolic pulmonary hypertension[J].Respir Res,2020,21(1):204.
[3] HUANG T, BEDFORD H M, RASHID S, et al. Modified multiple marker aneuploidy screening as a primary screening test for preeclampsia[J].BMC Pregnancy Childbirth,2022,22(1):190192.
[4] STEPAN H, HUND M, ANDRACZEK T. Combining biomarkers to predict pregnancy complications and redefine preeclampsia: the angiogenic-placental syndrome[J].Hypertension,2020,75(4):918-926.
[5] BROWN M A, MAGEE L A, KENNY L C, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice[J].Hypertension,2018,72(1):24-43.
[6] 谢幸,苟文丽.妇产科学[M]. 8版.北京:人民卫生出版社,2013:78-82.
[7] 王浡,李九霞,吕怡翔. 彩色多普勒超声评估晚发型胎儿宫内生长受限血流动力学变化及临床意义[J].包头医学,2022,46(4):19-20.
[8] 王波,吴腊梅,王凤琴. 孕中期多普勒超声联合血清学标志物检测预测胎儿宫内生长受限的研究[J].中国优生与遗传杂志,2022,30(11):1948-1952.
[9] 胡明茜,符燕鸣,陈建发. 三维超声容积测量联合二维超声在妊娠早期胎儿宫内生长受限诊断中的应用[J].黑龙江医学,2022,46(18):2217-2219.
[10] 吴青京,陈昌钊,符俊娟. 孕中期子宫动脉超声联合性激素检测预测晚发型胎儿宫内生长受限[J].中国计划生育学杂志,2022,30(8):1893-1896.
[11] 黄艳莉,张碧苗,杨建恩. 孕妇血清PAPP-Aβ-HCG水平与子痫前期及胎儿宫内生长受限的相关性分析[J].基层医学论坛,2022,26(1):72-73.
[12] JOHNSON S, LIU B, KALAFAT E, et al. Maternal and perinatal outcomes of white coat hypertension during pregnancy: a systematic review and Meta-analysis[J].Hypertension,2020,76(1):157-166.
[13] 高文凯,王瑞玲,王凤梅. 孕晚期宫内生长受限胎儿彩色多普勒血流显像相关参数变化及临床意义[J].湖南师范大学学报(医学版),2021,18(1):150-154.
[14] 侯丽颖,李百玲. 彩色多普勒超声评价胎儿宫内生长受限的研究进展[J].影像研究与医学应用,2020,4(23):5-6.